TRV GP III’s Pliant Therapeutics PLRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $6.14M | Hold |
339,160
| – | – | 100% | 1 |
|
|
2023
Q3 | $5.88M | Hold |
339,160
| – | – | 100% | 1 |
|
|
2023
Q2 | $6.15M | Sell |
339,160
-1,500,000
| -82% | -$27.2M | 33.71% | 2 |
|
|
2023
Q1 | $48.9M | Hold |
1,839,160
| – | – | 58.97% | 1 |
|
|
2022
Q4 | $35.6M | Sell |
1,839,160
-2,000,000
| -52% | -$38.7M | 27.86% | 2 |
|
|
2022
Q3 | $80.2M | Sell |
3,839,160
-2,000,000
| -34% | -$41.8M | 35.02% | 1 |
|
|
2022
Q2 | $46.8M | Hold |
5,839,160
| – | – | 19.13% | 2 |
|
|
2022
Q1 | $40.9M | Hold |
5,839,160
| – | – | 11.11% | 4 |
|
|
2021
Q4 | $78.8M | Hold |
5,839,160
| – | – | 19.73% | 2 |
|
|
2021
Q3 | $98.6M | Hold |
5,839,160
| – | – | 18.71% | 3 |
|
|
2021
Q2 | $170M | Hold |
5,839,160
| – | – | 29.69% | 2 |
|
|
2021
Q1 | $230M | Hold |
5,839,160
| – | – | 29.05% | 2 |
|
|
2020
Q4 | $133M | Hold |
5,839,160
| – | – | 11.39% | 4 |
|
|
2020
Q3 | $132M | Hold |
5,839,160
| – | – | 11.11% | 4 |
|
|
2020
Q2 | $190M | Buy |
+5,839,160
| New | +$190M | 27.66% | 2 |
|